These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1227292)

  • 41. Follow-up study of subjects on methadyl acetate and methadone.
    Charuvastra VC; Panell J; Ling W; Ouren J
    Drug Alcohol Depend; 1980 Nov; 6(5):273-84. PubMed ID: 7460760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comments on Ritter et al.'s report of a comparative trial of LAAM and methadone maintenance.
    Caplehorn J
    Addiction; 2004 Apr; 99(4):509-10; author reply 510-1. PubMed ID: 15049750
    [No Abstract]   [Full Text] [Related]  

  • 43. The future of LAAM.
    Renault PF
    NIDA Res Monogr; 1978; (19):291-3. PubMed ID: 106294
    [No Abstract]   [Full Text] [Related]  

  • 44. Therapeutic effects of methadone and 1-alpha-acetylmethadol.
    Karp-Gelernter E; Wurmser L; Savage C
    Am J Psychiatry; 1976 Aug; 133(8):955-7. PubMed ID: 942010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chromosomes in patients receiving methadone and methadyl acetate.
    Matsuyama SS; Charuvastra VC; Jarvik LF; Fu TK; Sanders K; Yen FS
    Arch Gen Psychiatry; 1978 Aug; 35(8):989-91. PubMed ID: 678048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of l-alpha-acetylmethadol in treatment of heroin addiction: an open study.
    Wilson BK; Spannagel V; Thomson CP
    Int J Addict; 1976; 11(6):1091-100. PubMed ID: 1025033
    [No Abstract]   [Full Text] [Related]  

  • 47. Withdrawal from heroin in three or six weeks. Comparison of methadyl acetate and methadone.
    Sorensen JL; Hargreaves WA; Weinberg JA
    Arch Gen Psychiatry; 1982 Feb; 39(2):167-71. PubMed ID: 7065831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The behavioral, cognitive and physiologic effects of long-term methadone and methadyl treatment. 1973 [proceedings].
    Irwin S; Blachly PH; Marks J; Carlson E; Loewen J; Reade N
    NIDA Res Monogr; 1976 Jul; (8):66-7. PubMed ID: 792699
    [No Abstract]   [Full Text] [Related]  

  • 49. Acceptability of methadyl acetate (LAAM) as compared with methadone in a treatment program for heroin addicts.
    Trueblood B; Judson BA; Goldstein A
    Drug Alcohol Depend; 1978 Mar; 3(2):125-32. PubMed ID: 631012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Every-other-day acetylmethadol disturbs circadian cycles of human motility.
    Crowley TJ; Jones RH; Hydinger-Macdonald MJ; Lingle JR; Wagner JE; Egan DJ
    Psychopharmacology (Berl); 1979 Apr; 62(2):151-5. PubMed ID: 111279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Episodes of heroin use during maintenance treatment with stable dosage of (-)-alpha-acetylmethadol (methadyl acetate, LAAM).
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1983 Jun; 11(3-4):271-8. PubMed ID: 6617466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Women on LAAM maintenance: initial experiences.
    Hargreaves WA; Ling W; Brown TC; Weinberg JA; Landsberg R; Harrison WL
    J Psychedelic Drugs; 1979; 11(3):223-9. PubMed ID: 575854
    [No Abstract]   [Full Text] [Related]  

  • 53. The phase III clinical evaluation of LAAM: I. Comparative epidemiology of mortality in LAAM and methadone.
    Thomas DB; Whysner JA; Newmann MC
    NIDA Res Monogr; 1979; 27():289-295b. PubMed ID: 121344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1-Acetylmethadol (LAM) treatment of opiate dependence: plasma and urine levels of two pharmacologically active metabolites, 1974.
    Billings RE; McMahon RE; Blake DA
    NIDA Res Monogr; 1976 Jul; (8):54. PubMed ID: 1088897
    [No Abstract]   [Full Text] [Related]  

  • 55. Methadyl acetate (LAAM) in the treatment of heroin addicts. II. Double-blind comparison of gradual and abrupt detoxification.
    Judson BA; Goldstein A; Inturrisi CE
    Arch Gen Psychiatry; 1983 Aug; 40(8):834-40. PubMed ID: 6347117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of clinic attendance schedules for LAAM and methadone: a controlled study.
    Karp-Gelernter E; Savage C; McCabe OL
    Int J Addict; 1982 Jul; 17(5):805-13. PubMed ID: 6752050
    [No Abstract]   [Full Text] [Related]  

  • 57. Failure of acetylmethadol in treatment of narcotic addicts due to nonpharmacologic factors.
    Segal R; Everson A; Sellers EM; Thakur R
    Can Med Assoc J; 1976 Nov; 115(10):1014-6. PubMed ID: 1032578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1982; 10(2-3):269-82. PubMed ID: 7166139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methadyl acetate versus methadone: the experience of one hospital.
    Panell J; Charuvastra VC; Ouren J
    Med J Aust; 1977 Jul; 2(5):150-2. PubMed ID: 331052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts. I. Dosage schedule for induction and stabilization.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1979 Nov; 4(6):461-6. PubMed ID: 533680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.